Anti-EGFR antibodies may get benefit as first-line treatment in metastatic right-sided colon cancer

被引：0
|
作者：
Elbaiomy, M. [1 ]
Elsayed, A. [2 ]
Akl, T. [1 ]
机构：
[1] Mansoura Univ, Oncol Ctr, Mansoura, Egypt
[2] Fac Med, Mansoura, Egypt
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.04.272
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-182
引用
收藏
页码：S314 / S315
页数：2
相关论文
共 50 条
  • [41] Hypomagnesemia is a reliable predictor for efficacy of anti-EGFR monoclonal antibody used in combination with first-line chemotherapy for metastatic colorectal cancer
    Fujii, Hironori
    Iihara, Hirotoshi
    Suzuki, Akio
    Kobayashi, Ryo
    Matsuhashi, Nobuhisa
    Takahashi, Takao
    Yoshida, Kazuhiro
    Itoh, Yoshinori
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (06) : 1209 - 1215
  • [42] Real-world data analysis of antiangiogenic targeted treatments in second-line following anti-EGFR antibodies and FOLFOX in first-line for patients with metastatic colorectal cancer
    Kagawa, Yoshinori
    Satake, Hironaga
    Shinozaki, Eiji
    Tanizawa, Yoshinori
    Cai, Zhihong
    Jin, Long
    Makiyama, Akitaka
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [43] Effect of RAS on anti-EGFR monoclonal antibodies plus 5-FU infusion-based chemotherapy in first-line treatment of metastatic colorectal cancer: A meta-analysis
    Zhou, Mingyi
    Yu, Ping
    Hou, Kazuo
    Jin, Bo
    Qu, Xiujuan
    Liu, Yunpeng
    Liu, Yunpeng
    Zhang, Jingdong
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [44] Subsequent anti-VEGF therapy after first-line anti-EGFR therapy improved overall survival of patients with metastatic colorectal cancer
    Qiu, Tianzhu
    Chen, Wensen
    Li, Ping
    Sun, Jing
    Gu, Yanhong
    Chen, Xiaofeng
    ONCOTARGETS AND THERAPY, 2018, 11 : 465 - 471
  • [45] Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: a retrospective multicenter study
    Grassadonia, Antonino
    Di Marino, Pietro
    Ficorella, Corrado
    Cortellini, Alessio
    Cannita, Katia
    Parisi, Alessandro
    Gamucci, Teresa
    Zoratto, Federica
    Vici, Patrizia
    Barba, Maddalena
    Porreca, Ettore
    Neri, Matteo
    Veronese, Angelo
    Natoli, Clara
    De Tursi, Michele
    Tinari, Nicola
    JOURNAL OF CANCER, 2019, 10 (24): : 5926 - 5934
  • [46] Laparoscopic right hemicolectomy with a cranial-first approach for right-sided colon cancer
    M. Koyama
    Y. Miyagawa
    M. Kitazawa
    S. Tokumaru
    S. Nakamura
    Y. Yamamoto
    T. Ehara
    N. Hondo
    Y. Soejima
    Techniques in Coloproctology, 2022, 26 : 919 - 920
  • [47] Laparoscopic right hemicolectomy with a cranial-first approach for right-sided colon cancer
    Koyama, M.
    Miyagawa, Y.
    Kitazawa, M.
    Tokumaru, S.
    Nakamura, S.
    Yamamoto, Y.
    Ehara, T.
    Hondo, N.
    Soejima, Y.
    TECHNIQUES IN COLOPROCTOLOGY, 2022, 26 (11) : 919 - 920
  • [48] The Best. First. Anti-EGFR before anti-VEGF, in the first-line treatment of RAS wild-type metastatic colorectal cancer: from bench to bedside
    Zaniboni, A.
    Formica, V.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (02) : 233 - 244
  • [49] The Best. First. Anti-EGFR before anti-VEGF, in the first-line treatment of RAS wild-type metastatic colorectal cancer: from bench to bedside
    A. Zaniboni
    V. Formica
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 233 - 244
  • [50] No benefit of extended mesenteric resection with central vascular ligation in right-sided colon cancer
    Olofsson, F.
    Buchwald, P.
    Elmstahl, S.
    Syk, I.
    COLORECTAL DISEASE, 2016, 18 (08) : 773 - 778
12345